title: Differential actions of pituitary adenylyl cyclase-activating polypeptide and interferon gamma on Th2- and Th1-associated chemokine expression in cultured murine microglia.
abstract: Microglia are the immune cells that reside in the central nervous system (CNS). Following the facial nerve injury in the mouse, microglia are activated in the facial motor nucleus, coincident with an increase in the proinflammatory cytokine interferon-gamma (IFN-γ). The authors have previously shown that maximal facial motoneuron (FMN) survival after injury depends on the CD4(+)T-cell interaction with microglia. Furthermore, it appears that the anti-inflammatory T helper (Th) 2 CD4(+) T-cell subset is required in the facial nucleus, although the mechanism of CNS recruitment is not known. Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a neuropeptide that has previously been demonstrated to be expressed by injured FMN. Interestingly, PACAP has been shown to act on peripheral macrophages by inducing chemokine expression capable of recruiting Th2 cells. Whether CNS-resident microglia, a related lineage to peripheral macrophages, respond to PACAP by expressing Th2-associated chemokines is not known. In this study, fluorescence-activated cell sorting was utilized to measure the frequency of microglia positive for different chemokines after exposure to various treatments. The results indicate that PACAP increases the frequency of microglia expressing Th2-associated chemokine, CCL11, and decreases the frequency of microglia expressing Th1-associated chemokine, CXCL11. In contrast, IFN-γ decreases the frequency of microglia expressing Th2-associated chemokine, CCL11, and increases the frequency of microglia expressing Th1-associated chemokine, CXCL11. Treatment with both PACAP and IFN-γ reversed the proinflammatory effect of IFN-γ. Given the recent focus on the therapeutic value of Th2 cells in the CNS during neurode-generative disease, PACAP may be a future therapeutic target for improving neuroregeneration after injury.
authors.affiliation: Department of Cell Biology, Neurobiology, and Anatomy, Loyola University Medical Center, Maywood, Illinois; Research and Development Service, Hines VA Hospital, Hines, Illinois.
authors.forename: Derek A
authors.initials: DA
authors.lastname: Wainwright
authors.forename: Junping
authors.initials: J
authors.lastname: Xin
authors.forename: Virginia M
authors.initials: VM
authors.lastname: Sanders
authors.forename: Kathryn J
authors.initials: KJ
authors.lastname: Jones
references.citation: J Neurochem. 2007 Sep;102(6):2008-2019
references.pmid: 17555556
references.citation: J Leukoc Biol. 2003 Jan;73(1):155-64
references.pmid: 12525573
references.citation: J Immunol. 1999 Oct 1;163(7):3629-35
references.pmid: 10490956
references.citation: J Neuroinflammation. 2007 Feb 28;4:9
references.pmid: 17328801
references.citation: J Neuroimmunol. 2007 Mar;184(1-2):100-12
references.pmid: 17198734
references.citation: J Neurosci. 1998 Aug 1;18(15):5804-16
references.pmid: 9671668
references.citation: J Neurosci Res. 2003 Oct 15;74(2):240-7
references.pmid: 14515353
references.citation: Med Hypotheses. 2008;70(2):413-8
references.pmid: 17582695
references.citation: FASEB J. 2004 Sep;18(12):1453-5
references.pmid: 15231725
references.citation: J Immunol. 1989 Feb 1;142(3):760-5
references.pmid: 2464024
references.citation: J Immunol. 1999 Apr 15;162(8):4685-96
references.pmid: 10202009
references.citation: J Immunol. 2007 Jun 15;178(12):7525-9
references.pmid: 17548586
references.citation: J Neuroimmunol. 2002 Dec;133(1-2):81-94
references.pmid: 12446011
references.citation: Exp Neurol. 2006 Sep;201(1):212-24
references.pmid: 16806176
references.citation: Brain Behav Immun. 2003 Oct;17(5):393-402
references.pmid: 12946661
references.citation: J Neurosci Res. 1999 Sep 15;57(6):953-61
references.pmid: 10467267
references.citation: Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10896-901
references.pmid: 9724801
references.citation: J Neuroimmunol. 1990 May;27(2-3):229-37
references.pmid: 2110186
references.citation: J Neuroimmunol. 2006 Mar;172(1-2):132-6
references.pmid: 16376995
references.citation: J Neurosci Res. 1999 Jan 1;55(1):127-34
references.pmid: 9890441
references.citation: J Leukoc Biol. 2004 Jun;75(6):1122-30
references.pmid: 15020654
references.citation: J Neurosci. 1999 Jun 1;19(11):RC7
references.pmid: 10341268
references.citation: Pharmacol Ther. 2003 May;98(2):245-55
references.pmid: 12725872
references.citation: J Neurosci. 2004 May 5;24(18):4333-9
references.pmid: 15128847